Literature DB >> 11450083

Postischemic hypothermia attenuates apoptotic cell death in transient focal ischemia in rats.

J Inamasu1, S Suga, S Sato, T Horiguchi, K Akaji, K Mayanagi, T Kawase.   

Abstract

Hypothermia confers potent neuroprotection against ischemic injury. Attenuation of apoptosis by hypothermia can be one of the responsible mechanisms. In this study, in situ DNA nick-end labeling (TUNEL) and immunostaining of Bax protein were performed to evaluate the effect of postischemic hypothermia on apoptotic cell death, employing rodent transient focal ischemia. Animals received 1 hour of transient focal ischemia. Brain temperature was maintained at 37.5 +/- 0.5 degrees C during ischemia. Immediately after reperfusion, animals were assigned to either a normothermic or hypothermic group. In hypothermia, animals were cooled and brain temperature was lowered to 34.5 +/- 1.0 degrees C. Prolonged hypothermia was maintained for 16 hours and animals rewarmed. In both groups, TUNEL and immunostaining of Bax was performed. In normothermia, the number of TUNEL positive cells reached the peak at 2 days after ischemia and decreased gradually. In hypothermia, the peak was shifted to 3 days after ischemia. The number of TUNEL positive cells in hypothermia was persistently below that of normothermia. Similarly, in hypothermia, immunostaining of Bax showed attenuated immunoreactivity compared with that in normothermia. In conclusion, postischemic hypothermia reduced both the number of TUNEL positive cells and immunoreactivity of Bax, which may be one of the responsible mechanisms with which hypothermia exerts neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11450083     DOI: 10.1007/978-3-7091-6346-7_110

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  14 in total

1.  Therapeutic applications of hypothermia in cerebral ischaemia.

Authors:  Bruno P Meloni; Frank L Mastaglia; Neville W Knuckey
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

2.  Hypothermia Identifies Dynamin as a Potential Therapeutic Target in Experimental Stroke.

Authors:  Jong Youl Kim; Nuri Kim; Jong Eun Lee; Midori A Yenari
Journal:  Ther Hypothermia Temp Manag       Date:  2017-06-30       Impact factor: 1.286

Review 3.  MR Thermometry in Cerebrovascular Disease: Physiologic Basis, Hemodynamic Dependence, and a New Frontier in Stroke Imaging.

Authors:  S Dehkharghani; D Qiu
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-05       Impact factor: 3.825

Review 4.  Therapeutic Hypothermia and Neuroprotection in Acute Neurological Disease.

Authors:  Kota Kurisu; Jong Youl Kim; Jesung You; Midori A Yenari
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

5.  Therapeutic hypothermia reduces cortical inflammation associated with utah array implants.

Authors:  Elizabeth A Dugan; Cassie Bennett; Ilmar Tamames; W Dalton Dietrich; Curtis S King; Abhishek Prasad; Suhrud M Rajguru
Journal:  J Neural Eng       Date:  2020-04-29       Impact factor: 5.379

Review 6.  Hypothermia as a cytoprotective strategy in ischemic tissue injury.

Authors:  Xian N Tang; Midori A Yenari
Journal:  Ageing Res Rev       Date:  2009-10-13       Impact factor: 10.895

7.  FasL shedding is reduced by hypothermia in experimental stroke.

Authors:  Liping Liu; Jong Youl Kim; Maya A Koike; Yone Jung Yoon; Xian Nan Tang; Hualong Ma; Hokyou Lee; Gary K Steinberg; Jong Eun Lee; Midori A Yenari
Journal:  J Neurochem       Date:  2008-04-12       Impact factor: 5.372

Review 8.  Hypothermic neuroprotection.

Authors:  A J Gunn; M Thoresen
Journal:  NeuroRx       Date:  2006-04

Review 9.  Metabolic downregulation: a key to successful neuroprotection?

Authors:  Midori Yenari; Kazuo Kitagawa; Patrick Lyden; Miguel Perez-Pinzon
Journal:  Stroke       Date:  2008-07-24       Impact factor: 7.914

Review 10.  Protection in animal models of brain and spinal cord injury with mild to moderate hypothermia.

Authors:  W Dalton Dietrich; Coleen M Atkins; Helen M Bramlett
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.